Cited by 19Sexual function and dysfunction studiesPelvic floor disorders treatmentsUrinary Bladder and Prostate Research

Treatments for Persistent Genital Arousal Disorder in Women: A Scoping Review

Open access
Martín-Vivar, María, Villena-Moya, Alejandro, Mestre-Bach, Gemma, Hurtado-Murillo, Felipe, Chiclana-Actis, Carlos·2022·The Journal of Sexual Medicine

Abstract

Background: Persistent genital arousal disorder (PGAD) is characterized by elevated discomfort associated with persistent genital arousal in the absence of sexual desire. Aim: To perform a scoping review of the proposed treatments for PGAD and their efficacy. Methods: A scoping review was carried out (PRISMA-Scr) that included articles on PGAD as the main disorder, only in women, which explained, in detail, the treatment and its efficacy, was empirical, was written in English and Spanish. No prior filtering by years was performed. Outcomes: Three different effective treatments were found (physical therapies, pharmacological therapies, and psychotherapeutics in combination with other therapies). Results: Thirty-eight articles were selected. From physical therapies, treatments using neuromodulation, transcutaneous electrical stimulation, Botox, surgery, electroconvulsive therapy, manual therapy, pelvic floor therapy, dietary changes, and transcranial magnetic stimulation showed effectiveness. Using the pharmacological approach, paroxetine, duloxetine, pramipexole, ropinirole, and clonazepam treatments were effective. Psychotherapy treatments showed effectiveness only in combination with other types of treatments, specifically a combination of cognitive–behavioral strategies with pharmacological treatment. Clinical implications: Pharmacological treatment, specifically SSRIs, have proven to be the therapy of choice for different subtypes of patients. Strengths and limitations: This study analyzed treatment effectiveness with different approaches and took into consideration those articles where psychotherapy was used as a combination treatment with pharmacological and physical therapy. The main limitation is that it was focused exclusively on women, and the results cannot be generalized to include men. Conclusions: To date, a combination of pharmacological interventions with physical therapy and, in some occasions, with psychological therapy is main strategy followed to accomplish effective treatment of PGAD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jsxm.2022.03.220

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Martín-Vivar, M., Villena-Moya, A., Mestre-Bach, G., Hurtado-Murillo, F., & Chiclana-Actis, C.
Affiliations
  • Universidad Francisco de Vitoria (ES)
  • Unidad de Sexología Clínica y Salud Sexual, Consulta Dr. Carlos Chiclana , Madrid , Spain
  • Universidad Internacional de la Rioja, Center for Sexual and Reproductive Health , La Rioja , Spain
  • Hospital Universitario Doctor Peset (ES)
Venue
The Journal of Sexual Medicine
Published
2022-04-06
Volume
19
Issue
6
Pages
961-974
ISSN
  • 1743-6095 (ISSN-L)
  • 1743-6109
OpenAlex
W4223590336
Cited by
19
References
56
Citations by year
2026: 1 · 2025: 9 · 2024: 6 · 2023: 3
FWCI
0.77
Type
journal article
Language
en
Open access
Locations
  • The Journal of Sexual Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Deposito Digital UFV (Francisco de Vitoria University) (submittedVersion, cc-by-nc-nd)
  • Re-Unir (International University of La Rioja) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Rheumatology › Pelvic floor disorders treatments
  • Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
Keywords
persistent genital arousal disorder, women, treatment efficacy, pharmacotherapy, selective serotonin reuptake inhibitors, paroxetine, duloxetine, pramipexole, ropinirole, clonazepam, neuromodulation, transcutaneous electrical stimulation, onabotulinumtoxinA, electroconvulsive therapy, pelvic floor physiotherapy, cognitive behavioral therapy, combination therapy, physiotherapy
MeSH terms
Urogenital Diseases, Arousal, Female, Genitalia, Humans, Libido, Male, Sexual Dysfunctions, Psychological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review